These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 8905477

  • 1. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 2. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 3. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 4. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.
    Ali I, James T, Meston N, Wojnarowska F, Shine B.
    Clin Chem Lab Med; 2009 Jun; 47(2):202-7. PubMed ID: 19191727
    [Abstract] [Full Text] [Related]

  • 5. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 6. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Apr 11; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 7. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May 11; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 8. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.
    Fertil Steril; 2003 Mar 11; 79(3):534-42. PubMed ID: 12620436
    [Abstract] [Full Text] [Related]

  • 9. Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens.
    Biglia N, Ambroggio S, Ponzone R, Sgro L, Ujcic E, Dato FA, Sismondi P.
    Maturitas; 2003 Aug 20; 45(4):283-91. PubMed ID: 12927315
    [Abstract] [Full Text] [Related]

  • 10. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May 20; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 11. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 20; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 12. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C, Colombo P, De Aloysio D, Gambacciani M, Grazioli I, Nappi C, Serra GB, Genazzani AR.
    Maturitas; 2002 Apr 25; 41(4):299-311. PubMed ID: 12034517
    [Abstract] [Full Text] [Related]

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 25; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 14. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V, Luisi S, Genazzani AD, Potì E, Genazzani AR.
    Maturitas; 2008 Apr 20; 59(4):293-303. PubMed ID: 18394829
    [Abstract] [Full Text] [Related]

  • 15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 20; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 16. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.
    Metabolism; 1997 Jan 20; 46(1):5-9. PubMed ID: 9005961
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels.
    Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa C, Peris C, Fiorucci GC, Sismondi P.
    Gynecol Endocrinol; 1993 Dec 20; 7(4):251-8. PubMed ID: 8147234
    [Abstract] [Full Text] [Related]

  • 18. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
    van der Klaauw AA, Biermasz NR, Zelissen PM, Pereira AM, Lentjes EG, Smit JW, van Thiel SW, Romijn JA, Roelfsema F.
    Eur J Endocrinol; 2007 Dec 20; 157(6):709-16. PubMed ID: 18057377
    [Abstract] [Full Text] [Related]

  • 19. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison.
    Castelo-Branco C, Martínez de Osaba MJ, Fortuny A, Iglesias X, González-Merlo J.
    J Reprod Med; 1995 Aug 20; 40(8):556-60. PubMed ID: 7473451
    [Abstract] [Full Text] [Related]

  • 20. Effects of bilateral ovariectomy and estrogen replacement therapy on serum leptin, sex hormone binding globulin and insulin like growth factor-I levels.
    Nar A, Demirtas E, Ayhan A, Gurlek A.
    Gynecol Endocrinol; 2009 Dec 20; 25(12):773-8. PubMed ID: 19905995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.